These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14698705)

  • 21. [Valproate (depakine chrono) in adult patients with partial epilepsy: results of a multicentral prospective non-comparative study].
    Gekht AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(4):27-31. PubMed ID: 22810737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment gaps of epilepsy and retention rates of sodium valproate in rural Guangxi, China.
    Huang DH; Zheng JO; Chen J; Yu L
    Genet Mol Res; 2014 Aug; 13(3):6202-12. PubMed ID: 25158247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium valproate for epilepsy in rural China: an efficacy and safety assessment in primary care.
    Wang W; Wu J; Li S; Ru X; Zheng J; Zhu S; Sander JW
    Epilepsy Res; 2012 Dec; 102(3):201-5. PubMed ID: 22809651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis.
    Aberg LE; Bäckman M; Kirveskari E; Santavuori P
    Epilepsia; 2000 Oct; 41(10):1296-302. PubMed ID: 11051125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life and treatment satisfaction in Spanish epilepsy patients on monotherapy with lamotrigine or valproic acid.
    Viteri C; Codina M; Cobaleda S; Lahuerta J; Barriga J; Morales MD;
    Seizure; 2010 Sep; 19(7):432-8. PubMed ID: 20663691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A controlled study with taltrimide and sodium valproate: valproate effective in partial epilepsy.
    Iivanainen M; Waltimo O; Tokola O; Parantainen J; Tamminen M; Allonen H; Neuvonen PJ
    Acta Neurol Scand; 1990 Aug; 82(2):121-5. PubMed ID: 2124033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential impact of contraceptive methods on seizures varies by antiepileptic drug category: Findings of the Epilepsy Birth Control Registry.
    Herzog AG; Mandle HB; Cahill KE; Fowler KM; Hauser WA
    Epilepsy Behav; 2016 Jul; 60():112-117. PubMed ID: 27206228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH; Michel NC; McNew CD; Lehman EB
    Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
    Biton V; Mirza W; Montouris G; Vuong A; Hammer AE; Barrett PS
    Neurology; 2001 Jan; 56(2):172-7. PubMed ID: 11160951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures.
    Marson AG; Williamson PR; Taylor S; Maguire M; Chadwick DW
    Neurology; 2006 Nov; 67(10):1872-5. PubMed ID: 17130429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
    Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
    Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Depakine in the therapy of epilepsy in children and adolescents].
    Guzeva VI; Fomina MIu; Korostovtsev DD; Guzeva VV; Guzeva OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(8):34-9. PubMed ID: 18379470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Valproate in the treatment of epilepsy in people with intellectual disability.
    Friis ML
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():32-5. PubMed ID: 10030429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered pharmacokinetics and metabolism of valproate after replacement of conventional valproate with the slow-release formulation in epileptic patients.
    Kondo T; Tokinaga N; Suzuki A; Ono S; Yabe H; Kaneko S; Hirano T
    Pharmacol Toxicol; 2002 Mar; 90(3):135-8. PubMed ID: 12071334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rapid change to monotherapy with valproic acid in children.
    Hurst DL
    J Child Neurol; 1993 Oct; 8(4):357-9. PubMed ID: 8228032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Investigation of efficacy of convulex-retard in epilepsy treatment].
    Gromov SA; Korovina SA; Eroshina ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(5):35-7. PubMed ID: 16768223
    [No Abstract]   [Full Text] [Related]  

  • 38. Epilim chrono: a multidose, crossover comparison of two formulations of valproate in healthy volunteers.
    Roberts D; Easter D; O'Bryan-Tear G
    Biopharm Drug Dispos; 1996 Mar; 17(2):175-82. PubMed ID: 8907724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 6-month prospective study on efficacy safety and QOL profiles of extended-release formulation of valproate in patients with epilepsy.
    Yu PM; Zhu GX; Wu XY; Li T; Xu L; Yue L; Wang B; Hong Z
    Seizure; 2011 Jan; 20(1):23-6. PubMed ID: 20951067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.